Proposed Breast Lump (FMTVDM/BEST) Pathway
Nuclear Imaging Protocol

Richard M Fleming; Matthew R Fleming; Tapan K Chaudhuri; Andrew McKusick; William C Dooley

Review Article

Proposed Breast Lump (FMTVDM/BEST) Pathway Nuclear Imaging Protocol

Richard M Fleming¹*, Matthew R Fleming¹, Tapan K Chaudhuri², Andrew McKusick^1,3 and William C Dooley⁴

¹FHHI-Omnific Imaging-Camelot, USA

²Eastern Virginia Medical School, USA

³Sebec Consulting & Media, North Carolina

⁴Oklahoma University Health Science Center, USA

Corresponding Author

Received Date: June 24, 2019; Published Date: June 28, 2019

Abstract

One of the major problems associated with the “screening” of women and men for breast cancer is the utilization of several “qualitative” imaging studies associated with sensitivity and specificity problems. According to the National Cancer Institute (NCI), 10% of all women who don’t have breast cancer are told they have breast cancer based upon the results of a “screening” mammogram.

Keywords: Breast lump; Breast cancer; Breast inflammation; Transitional breast changes; Breast treatment; Primary and secondary breast cancer

Article Details

Citation

Richard M F, Matthew R F, Tapan K C, Andrew M, William C D. Proposed Breast Lump (FMTVDM/BEST) Pathway Nuclear Imaging Protocol. Adv Can Res & Clinical Imag. 1(5): 2019. ACRCI.MS.ID.000524.